Article Text

Download PDFPDF

Physician-assisted death with limited access to palliative care
  1. Joaquín Barutta1,2,
  2. Jochen Vollmann1
  1. 1Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Bochum, Germany
  2. 2Department of Medical Humanities, Italian Hospital University, Buenos Aires, Argentina
  1. Correspondence to Dr Joaquín Barutta, Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Malakowturm—Markstr. 258a, Bochum D-44799, Germany; Joaquin.Barutta{at}ruhr-uni-bochum.de

Abstract

Even among advocates of legalising physician-assisted death, many argue that this should be done only once palliative care has become widely available. Meanwhile, according to them, physician-assisted death should be banned. Four arguments are often presented to support this claim, which we call the argument of lack of autonomy, the argument of existing alternatives, the argument of unfair inequalities and the argument of the antagonism between physician-assisted death and palliative care. We argue that although these arguments provide strong reasons to take appropriate measures to guarantee access to good quality palliative care to everyone who needs it, they do not justify a ban on physician-assisted death until we have achieved this goal.

  • Euthanasia
  • Palliative Care
  • End of Life Care
  • Public Policy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Introduction

Eric and John, each 65 years old, have advanced cancer with no prospects of recovery. Eric receives medical attention from an interdisciplinary team trained in palliative care (PC) that also provides home care. As a result, he has no severe symptoms. By contrast, such a level of care in John's city is very rare. Instead, he receives medical attention at the hospital from a physician with no formal training in PC. Unlike Eric, John has been experiencing a lot of suffering during recent months caused by feelings of loss of dignity along with severe pain and nausea. He does not wish to live in this situation any longer, and he recently made a request for physician-assisted death (PAD).

There are no doubts that the situation faced by John is a very serious one, not only because of the severity of his disease, but also because it reveals limitations in access to PC, either provided by a specialist or a general practitioner adequately trained, that still persists in both poor and rich countries. However, the question we wish to answer is whether PAD should be banned where access to PC is limited since otherwise some patients might request it who would choose to live if they were offered better care. George et al, for example, hold that “although the presence of specialist palliative care is no argument against therapeutic killing, its absence certainly is”.1 In this paper, we describe the main arguments that are commonly used to support this claim and assess whether they justify forbidding PAD in these circumstances.

General justification for PAD

Before proceeding with our analysis, it is appropriate to say a few words about the general justification for legalising PAD. Briefly, two claims play the main role. The first one, based on the value of autonomy, holds that granting an autonomous request for PAD is morally good because it allows patients to influence the timing and the process of dying according to their own preferences and goals. The second one, based on the value of well-being, holds that granting an autonomous request for PAD is morally good because it removes unbearable suffering that has no prospects of recovery and that cannot be relieved by other reasonable means. However, even among those who are generally in favour of legalising PAD, some argue that this is justified only if good quality PC is widely accessible. Otherwise, they claim, PAD should be banned until this goal is achieved. Four arguments are normally used to support this claim, which we discuss next.

Assessment of the main arguments

The first argument against legalising PAD where access and quality of PC is limited we call the argument of lack of autonomy. Although there are patients who choose PAD without exhausting all palliative treatments first, most of them do not.2 Patients who lack access to good quality PC cannot choose this option. Consequently, some of them might request PAD in order to avoid suffering even though they would choose better care if this were available. According to this argument, whether such choices are autonomous should be doubted. However, if PAD is legalised in these circumstances, some patients might request it who might lack the autonomy to make this decision. This is the stance of Mary Shariff, for example, when she claims that good PC should be guaranteed before legalising PAD because otherwise “there is a risk that a patient's request for assisted death will lack consent because of the absence of meaningful choice”.3

Certainly, a lack of better options limits the choices a person has available. However, an autonomous decision is not the same as a decision after trying all other options. We should not demand that a patient's decision coincides with the decision they would make under ideal circumstances to consider it autonomous, and therefore, worthy of our respect. All we should require is that their choice is the result of correctly applying the skills needed to make a decision based on their own values and beliefs.4 Although there is no absolute consensus, it is generally accepted that this follows when the patient is competent, sufficiently informed and free from controlling influences, such as manipulation or coercion.5 ,6 Regarding the first condition, it would be mistaken to assume that the presence of suffering in these patients, including physical pain, undermines competence.7 This aptitude must be assessed in each patient, and relatively to the decision to request PAD. Nor should there be impediments to the provision of information in such cases. As for the last condition, physicians should assess whether the patient is being manipulated or coerced, just as they should do with any important medical decision including, for instance, a request for palliative sedation. Some claim that the very absence of palliative options necessarily coerces patients. However, we believe that this results from a misguided tendency to regard every serious situation in which the patient has to make a very difficult decision as coercion.6 Assessing the capacity of healthcare systems to relieve suffering is essential for a patient to make a rational choice based on their preferences. Therefore, we believe that PAD should not be banned where access to PC is limited on the basis that limited access to PC prevents an autonomous choice.

The second argument against legalising PAD where good quality PC is not widely available we call the argument of existing alternatives. According to this, PAD should be a measure of last resort to turn to only when all alternatives have been exhausted. However, if PAD is legalised in these circumstances, some patients might request it who could still benefit from better palliative options. Michael Gill, for example, warns that we should perhaps forbid physician-assisted suicide where good PC is not widely available because “it is uncontroversially regrettable if a person commits suicide but would not have done so if her end-of-life care had been better”.8 Although the focus of this article is not restricted to physician-assisted suicide, this quotation is intended to illustrate an argument raised against legalising PAD more generally when access to PC is still limited.

We share the view that it is highly regrettable if a patient requests PAD only because good quality PC is not being received. However, denying PAD because there are palliative alternatives somewhere that could relieve the patient's suffering results in more suffering. Where these options are not available, it is simply impossible to relieve suffering by means of them. If we forbid PAD until this situation has changed, we remove the only option left for many patients to avoid further suffering in the meantime.9 As a result, we condemn many of them to a worse death. Moreover, we interfere with the autonomous decision of these patients to request PAD that we have discussed previously. Since doing so results in more suffering, it is hard to see how this could be justified using this argument. As an additional point, it is also worth noting that PC cannot remove all requests for PAD. Most patients request PAD driven by feelings of loss of dignity or autonomy that are often very resistant even to good quality PC.10 ,11 Therefore, we believe that PAD should not be banned where access to PC is limited on the basis that there are still palliative options somewhere that could relieve suffering.

The third argument, which we call the argument of unfair inequalities, focuses on the fact that limited access to PC often affects specifically, or predominantly, those economically least advantaged. If PAD is legalised in these circumstances, some of these patients might request it only because they cannot afford better medical care. Since appropriate PC should not be limited to those who have more money, this situation would be unfair. In a similar vein, Joanne Lynn claims that endorsing death for the poor “because our community does not provide the care they need should be a terrifying prospect”.12 This argument has been raised more usually in countries that lack universal coverage of healthcare such as the USA and South America.

The available evidence shows that PAD is actually more frequent among the affluent than the poor.13 However, this observation does not entail that some patients among the latter do not, or will not, request PAD because they cannot afford good quality PC. Several other reasons may explain a higher prevalence of PAD among the affluent, including differences in views about dignity or autonomy and, perhaps, even differences in access to this alternative. Hence, this argument posits a serious challenge. Nevertheless, even if some requests for PAD derive from lack of economic resources to get better care, forbidding PAD does nothing to help these patients. On the contrary, as already noticed when analysing the previous argument, it reduces their options even more, condemning many of them to a worse death. The real problem that we should address is the unfair distribution of care. Legislation on PAD should be accompanied by a commitment to guarantee that PC will be accessible for everyone, regardless of their economic situation, within the shortest possible time. In the meantime, physicians should seek help through public agencies to relieve the suffering of these patients and good monitoring should be carried out to assess whether legalising PAD leads to unfair inequalities in a specific social context, but PAD should not be denied until this problem has been solved.14 Therefore, we hold that this argument also fails to justify a ban on PAD where access to PC is limited.

The last argument against legalising PAD in these circumstances we call the argument of the antagonism between PAD and PC. According to this, legalisation of PAD hinders the development of PC by offering an alternative to it. A policy that hinders improvements in the access and quality of PC where this could alleviate the suffering of many patients, and thus, remove some requests for PAD, is a bad policy. This important point has been raised, among others, by the European Association for Palliative Care (EAPC).15

This argument can be challenged on the basis that a ban on PAD for the benefit of those who will suffer in the future does not give a fair treatment to those who are suffering today. Moreover, even if one denies that such would be unfair, the argument can still be challenged on empirical grounds, as the evidence shows that the prediction it makes is not necessarily true. In a report written at the request of EAPC, the authors concluded that PC is well developed in countries where PAD is legal, and that the idea that legalisation hinders the development of PC lacks empirical support.16 Moreover, research shows that PC and PAD collaborate to remove the patient's suffering, rather than acting as opposing forces.17 Social and political pressure resulting from legislation may also contribute to improve access to PC. Admittedly, the outcomes might be different in different social contexts, and this empirical hypothesis should be assessed in every case before legalising PAD. Contexts where significant discrimination exists are especially important. However, unless there are strong reasons indicating that legalisation will have this effect, we believe that a ban on PAD is not justified. However, adequate legislation and education, as well as good monitoring of the development of PC, are necessary.

Conclusion

Requests for PAD by patients without access to good quality PC confront us with a very hard decision. On the one hand, granting a request for PAD without first offering the best level of care that exists today raises ethical concerns. On the other hand, denying PAD because we have not yet managed to make such level of care accessible to all has the awkward implication that these patients would have to experience a worse death from their own point of view. However, because we did not find that the arguments analysed here show that PAD should never be legalised in these circumstances, we hold that it is justified to consider more permissive policies where PAD is still forbidden. This does not undermine the fact that it is morally wrong if people are suffering because we are not doing what is morally required from us. However, this would be a compelling reason to fulfil our duties as a society, but not to deny PAD to patients who are suffering today and request it autonomously.

References

View Abstract

Footnotes

  • Contributors JB is an international postdoctoral fellow from Argentina at the Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Germany, and a lecturer on medical humanities at the Italian Hospital University in Argentina. JV is Professor and Director at the Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Germany. This article combines both normative work and empirical data from peer-reviewed journals and books to identify the arguments addressing this topic and analyse them. JB was in charge of writing the article, and both authors contributed equally to the content.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles